SEC Filing Update: #MBX MBX Biosciences, Inc. : $66.15

Sector: Healthcare | YTD: 🔼+ 116.74% The SEC disclosed Today (10-AUG-2026) that ORBIMED ADVISORS LLC has DECREASED #MBX Shares by -15.48% 🔴 * Previous Holdings: 3.64M Shares * Current Holdings: 3.07M Shares * Decrease -563.03K * Decreased (%)-15.48% * Ownership: 6.4% https://www.thinksabio.com/reports/isr/MBX Institutional ownership in #MBX has been steadily rising over the past 8 quarters in Shares: Q2 2024: 0.00 Q3 2024: 30.28M Q4 2024: 32.94M Q1 2025: 35.67M Q2 2025: 36.84M Q3 2025: 47.79M Q4 2025: 48.43M Q1 2026: 52.54M The quarterly average prices of #MBX: Q3 2025: $13.38 Q4 2025: $24.14 Q1 2026: $34.01 📌 Institutional activity in the last 30 days for #MBX: • BLACKROCK INC – Increased holdings by 340,684 shares (29-JUL-2026)